Agios Pharmaceuticals, Inc. (AGIO)
27.21
+0.23
(+0.85%)
USD |
NASDAQ |
May 07, 10:28
Agios Pharmaceuticals Free Cash Flow : -384.73M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.316B |
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Eli Lilly & Co. | 10.37B |
| Apellis Pharmaceuticals, Inc. | 45.01M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -118.92M |
| Cash from Investing (Quarterly) | 141.31M |
| Cash from Financing (Quarterly) | 2.078M |
| Free Cash Flow Per Share (Quarterly) | -2.036 |
| Free Cash Flow to Equity (Quarterly) | -115.23M |
| Free Cash Flow to Firm (Quarterly) | -119.69M |
| Free Cash Flow Yield | -24.25% |